Sun Pharma to test pancreatitis drug in COVID-19 patients in India

BENGALURU (Reuters) - Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indian regulatory approval to start clinical trials of a pancreatitis drug in COVID-19 patients.

29 May 11:01 • Reuters • 8334514180344297342.html

Sun Pharma to test pancreatitis drug in Covid-19 patients in India

Sun Pharma it has initiated manufacturing of the active pharmaceutical ingredient and the finished product of the drug using technology from its unit, Pola Pharma Japan.

29 May 11:20 • Business-Standard • 1502508925866512974.html

Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

29 May 11:17 • Firstpost • 4760741712166557226.html